The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Gabriel Vallecillo, MD; María José Robles, MD; Marta Torrens, MD; Pilar Samos, RN; Albert Roquer, RN; Paula K. Martires, RN; Arantza Sanvisens, MPH; Roberto Muga, MD; & Juan Pedro-Botet, MD
Substance Abuse Vol. 39, Iss. 1, 2018
“The results of this observational study show an elevated prevalence of overweight and metabolic syndrome in individuals with heroin use disorder on methadone therapy. These findings have significant implications for clinicians due to the increasing number of individuals on long-term methadone therapy and the progressive aging of this population. Therefore, the prevention of obesity and the diagnosis of the metabolic syndrome should be included in the clinical routine of this population with the aim of reducing the risk of developing diabetes and cardiovascular diseases in the future.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!